FDA Inspection
Anuj Bhargava MDAnuj Bhargava MD – FDA Inspection, Sep 27, 2019
Record Details
This FDA Inspection record concerns Anuj Bhargava MD, with an inspection on September 27, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Person
- Debra L. Boyd Seale (Issuing Officer)
View Company Profile
ID · 7e591a87-d6f9-4752-8083-b084f8c8bfaa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1108759
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Anuj Bhargava MD
4| Date | Classification | Office | Project area |
|---|---|---|---|
| April 24, 2026 | Not classified | Kansas City District Office | Bioresearch Monitoring |
| December 17, 2020 | VAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| April 7, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 18, 2014 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Anuj Bhargava MD
- FDA Inspection 1314648 - 2026-04-24
- FDA Inspection 1134357 - 2020-12-17
- FDA Inspection 1009644 - 2017-04-07
- FDA Inspection 866334 - 2014-02-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.